Developing treatments using monoclonal antibodies to fight malaria
SBIR Topic 109: Development of Monoclonal Antibody- Mediated Interventions to Combat Malaria
This study is looking for ways to create new treatments for malaria using special antibodies that can help fight the disease, and if you're interested, you might have a chance to join trials to see how safe and effective these treatments are.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cure Systems LLC NIH-funded |
| Lab location | 1 site (Newton Center, United States) |
| Project ID | NIH-11203270 on NIH RePORTER |
What this research studies
This research focuses on creating monoclonal antibody-based treatments aimed at combating malaria, a serious infectious disease caused by Plasmodium parasites. The approach involves developing specific antibodies that can target and neutralize the malaria-causing agents in the body. By leveraging advanced techniques in antibody development, the research aims to provide effective interventions that could significantly reduce malaria infections and improve patient outcomes. Patients may have the opportunity to participate in trials assessing the safety and efficacy of these new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk of malaria infection, particularly those living in endemic regions.
Not a fit: Patients who are not at risk of malaria or those who have already been treated for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for malaria, potentially saving lives and reducing the burden of the disease.
How similar studies have performed: Other research has shown promise in using monoclonal antibodies for infectious diseases, indicating potential success for this approach in combating malaria.
Where this research is happening
Newton Center, United States
- Cure Systems LLC — Newton Center, United States (Active)
Researchers
- Principal investigator: Miller, Jacqueline — Cure Systems LLC
- Study coordinator: Miller, Jacqueline
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.